How China became the new world leader in clinical trials

Puntos clave

• China has significantly increased its investment in medical research, strengthening its global standing in clinical trials.
• The country’s advancements position it to capitalize on weaknesses in the US medical research sector, with billions invested over decades.
• Geopolitical factors and local challenges may complicate China’s dominance in the clinical trials landscape.
• China's status as a scientific superpower influences both domestic and international research initiatives.

Resumen